David Oxley Email & Phone Number
CEO, Vaccinogen | OncoVAX®— Immunotherapy to Prevent Stage II Colon Cancer Recurrence @ Vaccinogen
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
David Oxley Location
- United States
David Oxley Work
- CEO, Vaccinogen | OncoVAX®— Immunotherapy to Prevent Stage II Colon Cancer Recurrence @ (November 2025 - Present)
- Chief Executive Officer @ (October 2025 - Present)
- Member Board of Directors @ (June 2025 - Present)
- Board Member @ (February 2025 - Present)
- Chief Business Officer @ (February 2023 - November 2025)
- President International @ (August 2021 - January 2023)
- Sr. Vice President, Business Development and Licensing @ (August 2017 - September 2022)
- Senior Vice President Business Development @ (January 2017 - January 2022)
- Principal @ David Oxley LLC (January 2016 - August 2017)
- Board Director @ (July 2013 - April 2016)
- Chief Executive Officer @ Lorem Vascular Pte, Ltd. (January 2013 - January 2016)
- Interim CEO @ Lorem Vascular, Pty. Ltd. (November 2014 - November 2015)
- Senior Vice President, Emerging Markets and General Manager China, VP Emerging Markets, VP Marketing @ (August 2009 - September 2014)
- Executive Vice President, World Wide Sales and Marketing @ (October 2006 - August 2009)
- Vice President Government Affairs @ (January 2002 - January 2006)
- Financial Consultant, Private Asset Management @ (March 2000 - May 2002)
- Public Affairs and Legislative Affairs Specialist @ (June 1993 - February 2000)
- Lobbyist @ (January 1993 - January 1998)
- Staff @ U.S. House of Representatives (January 1991 - January 1993)
- Health Specialist @ Office of U.S. Representative Ron Wyden (January 1991 - January 1993)
David Oxley Education
- The Johns Hopkins University
M.S. in Government & Public Health (Government Public Health)
1996-1998 - Portland State University
B.S. in History
David Oxley Skills
- Biologics
- Biomarkers
- Biomedical Engineering
- Biotechnology
- Biotechnology Strategy, Capital Formation, Cross-Border Licensing & M&A, Clinical Development Oversight, Board Governance
- Business Development
- Business Planning
- Business Strategy
- Capital Equipment
- Capital Markets
- Cardiology
- Clinical Development
- Clinical Research
- Clinical Trials
- Commercialization
- Competitive Analysis
- Congressional Lobbying
- Contract Negotiation
- Cross-border M&A
- Cross-border Transactions
- Cross-functional Team Leadership
- Dividends
- Equity Capital Markets
- FDA
- Financial Advisory
- Fundraising
- Government Procurement
- Growth Strategies
- HKEX
- Hardware Diagnostics
- Health Policy
- Healthcare
- High Performance Organizations
- High Performance Teams
- Hong Kong stock exchange
- ISO 13485
- Infectious Diseases
- International Sales
- Leadership
- Licensing Negotiations
- Lifesciences
- Manufacturing
- Market Analysis
- Market Development
- Marketing
- Marketing Strategy
- Medical Devices
- Mergers & Acquisitions
- NASD
- NASDAQ
- NYSE
- Neurology
- Neuropathology
- New Business Development
- New company formation
- Oncology
- Orthopedic
- Pharmaceutical Industry
- Pre-IPO
- Product Development
- Product Launch
- Product Management
- Product Marketing
- Quality System
- R&D
- Regulatory Affairs
- Resourcing Strategies
- Sales
- Sales Management
- Sales Operations
- Start-ups
- Strategic Architecture
- Strategic Partnerships
- Strategic Planning
- Strategic Repositioning
- Strategy
- Technology Transfer
- Translational Medicine
- Wall Street
David Oxley Summary
- David Oxley, based in United States, is currently a CEO, Vaccinogen | OncoVAX®— Immunotherapy to Prevent Stage II Colon Cancer Recurrence at Vaccinogen. David Oxley brings experience from previous roles at Vaccinogen, Caladrix and BIORCHESTRA Co., Ltd.. David Oxley holds a 1996 - 1998 M.S. in Government & Public Health in Government Public Health @ The Johns Hopkins University. With a robust skill set that includes Biologics, Biomarkers, Biomedical Engineering, Biotechnology, Biotechnology Strategy, Capital Formation, Cross-Border Licensing & M&A, Clinical Development Oversight, Board Governance and more. David Oxley has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different David Oxley?
Find contact details for 700 million professionals.
Others Named David Oxley
Top Vaccinogen Employees
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co